A comparison of Dual triggering by administration of GnRH agonist plus HCG versus HCG in poor responders in ART outcomes

A comparison of Dual triggering versus HCG in poor responders in ART outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016111628756N4

Enrollment

Registered

2016-12-04

Start date

2016-05-01

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility of other origin

Interventions

Intervention 1: in intervention group co-administration of HCG and agonist used for triggering. Intervention 2: in control group HCG used routinely for triggering.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: poor ovarian responders women (based on Bologna criteria) GnRH antagonist protocols fresh embryo transfer

Exclusion criteria

Exclusion criteria: endometrial polyps presence of endocrine disorders (such as hyperprolactinemia, hypothyroidism) preimplantation genetic diagnosis cycles non fresh embryo transfer cycles.

Design outcomes

Primary

Measure	Time frame
Number of metaphase II oocytes. Timepoint: After intervention. Method of measurement: number.	—

Secondary

Measure	Time frame
Number of fertilized oocytes (2PN). Timepoint: after intervention. Method of measurement: number.;Clinical pregnancy. Timepoint: 28 days after transfer. Method of measurement: 28 days after transfer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Naghshineh

research and clinical center for infertility

naghshineh@med.mui.ac.ir+98 35 3824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026